期刊文献+

通心络胶囊在心脏X综合征中的应用 被引量:12

Clinical Application of Tongxinluo Capsule in Cardiac Syndrome X
下载PDF
导出
摘要 目的:观察通心络胶囊治疗心脏X综合征的疗效。方法:确诊的心脏X综合征患者64例,随机分为对照组(n=30)和治疗组(n=34),治疗组在常规治疗的基础上加服通心络胶囊3粒,每日3次,连用4周,观察心绞痛症状及心电图缺血性ST-T改善情况。结果:与对照组相比,治疗组在治疗后无论是心绞痛症状还是心电图改善情况均有显著的疗效,并明显优于对照组,二者有显著性差异(P<0.05)。结论:通心络胶囊具有保护血管内皮功能,改善微血管循环障碍,提高冠状动脉血流储备能力,减少心绞痛的发作,改善心电图的异常改变。 Objective: To observe the clinical effect of Tongxinluo capsule in treating patients with cardiac syndrome X ( CSX ). Methods: The study was conducted on the 64 patients with CSX, who were randomly assigned to the control group ( n=30 ) and the treated group ( n=34 ), the treated with 3 Tongxinluo capsules in addition to conventional treatment, three times per day, the treatment course was 4 weeks. The change of such symptoms as angina pectoris and ECG ischemic ST-T were observed. Results: After treatment, such symptoms as angina pectoris and ECG ischemic ST-T in the treated group were improved more than those in the control group ( P〈0.05 ) .Conclusion: Tongxinluo capsule could protect the vascular endothelial function, improve microvascular circulation disorder, increase coronary flow reserve and reduce the frequency of angina attack and improve the abnormal change of ECG.
出处 《辽宁中医药大学学报》 CAS 2008年第10期82-83,共2页 Journal of Liaoning University of Traditional Chinese Medicine
关键词 心脏X综合征 通心络胶囊 cardiac syndrome X Tongxinluo capsule
  • 相关文献

参考文献5

二级参考文献21

  • 1第一届全国内科学术会议心血管病组.关于冠状动脉性心脏病命名及诊断标准的建议[J].中华心血管病杂志,1981,9(1):75-76.
  • 2Clarkson P, Cehrmajer DS, Powe AJ, et al. Endothelium dependent dilatation is impaired in yound healthy subjects with a family history of premature coronary disease. Circulation 1997;96(10) :3378-3383.
  • 3Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992 ;340 : 1111-1115.
  • 4Riner Z, Tedeschi RE. New information on the pathophysiology of atherosclerosis. Lijec Vjesn 2001;123(1-2):26-31.
  • 5Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993 ;362(6423) : 801-809.
  • 6Patel SS, Thiagarajan R, Willerson JT, et al. Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice.Circulation 1998;97(1):75-81.
  • 7Shih PT, Brennan ML, Vora DK, et al. Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet. Circ Res 1999;84(3) :345-351.
  • 8Sheridan PJ,Crossman DC. Practitioner, 2003; 247(1644):208-210.
  • 9Scholz M, Wegener K, Unverdorben M, et al. Herz, 2003 ;28(5) : 413-420.
  • 10Bugiardini R,Borghi A, Pozzati, et al. Am J Cardiol, 1993,72(3) :343-347.

共引文献341

同被引文献181

引证文献12

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部